Boston Scientific signs $3.7bn deal to acquire Axonics
Axonics is expected to report net revenue of around $366m in 2023, a 34% increase from the previous year.
09 January 2024
09 January 2024
Axonics is expected to report net revenue of around $366m in 2023, a 34% increase from the previous year.
The system features technology to capture brain signals and provides healthcare professionals with insights to tailor therapy.
The sensor provides glucose readings every minute, which are displayed on the pump and the t:connect mobile app.
The Dream Sock and BabySat infant monitoring devices recently clearance from the US Food and Drug Administration (FDA).
Qdose provides a dose assessment of absorbed radiation to organs and tissues caused by medically administered radiopharmaceuticals.
The company has made moves to expand its market by partnering with Hikma Pharmaceuticals to expand across the region.
Last week, the FDA’s Safer Technologies Program (STeP) accepted EndoQuest's flexible surgical robotic system.
The Cordella system aims to enhance the management of heart failure (HF) patients by providing proactive pulmonary artery pressure data.
GlobalData predicts that the major technology themes expected to influence the medical device industry in 2024 are AI, cybersecurity, robotics, AI regulation, and digitalization. Furthermore, remote patient monitoring and precision medicine have been identified as the major industry themes set to shape the the medical devices market in 2024.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Give your business an edge with our leading industry insights.